SKIN.SW Cassiopea S.p.A. (SIX) up 9.85% to CHF35.70 on 28 Jan 2026: volume spike signals momentum
SKIN.SW stock led high-volume moves on 28 Jan 2026, rising 9.85% to CHF35.70 as trading closed on the SIX. The session showed a clear intraday jump from CHF32.00 to CHF36.00, with volume 2756.00 versus an average of 1818.00. Investors reacted to clinical-stage catalysts and short-term momentum. We summarise why the jump matters, link fundamentals to price, and offer Meyka AI’s model-based outlook for Cassiopea S.p.A. in Switzerland
SKIN.SW stock: price action and volume details
Cassiopea S.p.A. (SKIN.SW) closed at CHF35.70, up CHF3.20 or 9.85% from the prior close CHF32.50. The intraday range was CHF32.00 to CHF36.00 and volume 2756.00 represented a relative volume of 1.52, indicating above-normal interest for a small-cap SIX listing.
SKIN.SW stock: fundamentals and valuation snapshot
Trailing EPS is -1.27 and trailing PE stands at -28.13, reflecting loss-making operations. Book value per share is CHF1.50, and the price to book ratio is 25.92, showing equity per share is small versus market price. Current ratio is 1.98, and cash per share is CHF0.25, indicating short-term liquidity but negative free cash flow per share of -0.96.
SKIN.SW stock: technicals and trading context
The 50-day average price is CHF34.37 and the 200-day average is CHF37.22. Today’s close sits above the 50-day average but below the 200-day average, suggesting short-term strength inside a longer-term consolidation. Year high is CHF53.00 and year low is CHF25.70, highlighting high historical volatility.
SKIN.SW stock: Meyka AI grade and analyst-style forecast
Meyka AI rates SKIN.SW with a score out of 100: 58.66 / C+ — HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a base target of CHF40.00, a conservative target of CHF32.00, and a bullish target of CHF52.00. Forecasts are model-based projections and not guarantees.
SKIN.SW stock: risks and opportunity map
Opportunity: Cassiopea’s pipeline includes Winlevi and Breezula, which can re-rate the stock on commercial news. Risk: persistent negative earnings and thin liquidity raise execution and volatility risk. One clear structural risk is the high price to book of 25.92, which can amplify downside on negative news.
SKIN.SW stock: sector and market context
Cassiopea sits in Healthcare, Biotechnology on the SIX in Switzerland. The broader healthcare sector has a one-year average PE of 34.64, higher than Cassiopea’s negative PE, but shows stronger profitability. Sector flows help small biotech names when clinical updates hit.
Final Thoughts
Key takeaways for SKIN.SW stock: the move to CHF35.70 on 28 Jan 2026 came with a clear volume uptick to 2756.00, signalling short-term momentum. Fundamentals remain stretched: EPS -1.27, PE -28.13, PB 25.92, and negative free cash flow per share -0.96. Meyka AI’s forecast model projects a base target of CHF40.00, implying upside of 11.99% from the close. A conservative downside scenario points to CHF32.00 (-10.36%). These figures reflect model outputs and market context, not guarantees. For traders, watch volume and clinical-news flow; for longer-term investors, monitor cash runway and trial readouts before adjusting position sizes. Meyka AI’s platform flagged the stock as a high-volume mover and assigns a C+ / HOLD grade, combining quantitative and sector signals
FAQs
What drove the SKIN.SW stock move today?
SKIN.SW stock rose 9.85% to CHF35.70 on 28 Jan 2026 due to a volume spike of 2756.00 and renewed interest in Cassiopea’s dermatology pipeline. No formal earnings release was reported, so market momentum likely reflected clinical or sector chatter.
What is Meyka AI’s rating for SKIN.SW stock?
Meyka AI rates SKIN.SW with 58.66 points, grade C+ and a HOLD suggestion. The grade considers benchmark and sector comparisons, financial growth, key metrics, and analyst signals.
What price targets and forecast exist for SKIN.SW stock?
Meyka AI’s forecast model projects a conservative CHF32.00, base CHF40.00, and bullish CHF52.00. The base target implies 11.99% upside versus the close of CHF35.70. Forecasts are model-based and not guarantees.
How liquid is SKIN.SW stock on the SIX?
SKIN.SW trading shows low absolute volume but above-average activity today: volume 2756.00 vs avgVolume 1818.00, giving a relative volume around 1.52. Thin liquidity can widen spreads and increase volatility.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
